Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes

被引:119
|
作者
Bo, S [1 ]
Cavallo-Perin, P [1 ]
Gentile, L [1 ]
Repetti, E [1 ]
Pagano, G [1 ]
机构
[1] Univ Turin, Dipartimento Med Interna, I-10126 Turin, Italy
关键词
creatinine clearance; insulin-resistance; macroalbuminuria; uric acid;
D O I
10.1046/j.1365-2362.2001.00812.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Design Conflicting data exist about uric acid levels in type 2 diabetes mellitus, as low levels were found in diabetic patients, while elevated serum uric acid is a feature of hyperinsulinemia and impaired glucose tolerance. The present study was addressed to evaluate the relation between uric acid and metabolic parameters, creatinine clearance and albumin excretion rate in a cohort of type 2 diabetic patients. Results Hyperuricemic patients were older and had higher values of body mass index (BMI), systolic and diastolic blood pressure, triglycerides, albumin excretion rate, C-peptide and prevalence of hypertension, metabolic syndrome and macroalbuminuria and lower values of high-density lipoprotein (HDL)-cholesterol creatinine clearance and glycated haemoglobin (HbA(1c)). The correlations between uric acid levels and triglycerides, BMI, systolic blood pressure, albumin excretion rate, C-peptide, creatinine clearance, HDL-cholesterol and HbA(1c) remained significant in a multiple regression analysis after adjustment for age, sex and duration of diabetes. After performing multiple logistic regression analyses, uric acid levels were independently associated with hypertension [odds ratio (OR) = 1.8; 95% confidence interval (CI) 1.6-2], after adjustment for age, sex, duration of diabetes and macroalbuminuria (OR = 1.5; 35% CI 1.1-2.0), after adjustment for age, sex, HbA(1c) levels, creatinine clearance, duration of diabetes and blood pressure levels and the metabolic syndrome (OR = 1.6; 95% CI 1.5-1.8), after adjustment for age, sex and creatinine clearance. Conclusions In type 2 diabetes, hyperuricemia seems to be associated with the insulin-resistant syndrome and with early onset or increased progression to overt nephropathy, while hypouricemia is associated with worse metabolic control, hyperfiltration and a late onset or decreased progression to overt nephropathy.
引用
收藏
页码:318 / 321
页数:4
相关论文
共 50 条
  • [31] Tale of two Indians: Heterogeneity in type 2 diabetes pathophysiology
    Staimez, Lisa R.
    Deepa, Mohan
    Ali, Mohammed K.
    Mohan, Viswanathan
    Hanson, Robert L.
    Narayan, K. M. Venkat
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (08)
  • [32] Nutrigenetics: Bridging Two Worlds to Understand Type 2 Diabetes
    Harrington, Janas M.
    Phillips, Catherine M.
    CURRENT DIABETES REPORTS, 2014, 14 (04)
  • [33] Association of GCKR rs780094 polymorphism with circulating lipid levels in type 2 diabetes and hyperuricemia in Uygur Chinese
    Wang, Li
    Ma, Qi
    Yao, Hua
    He, Li-Juan
    Fang, Bin-Bin
    Cai, Wen
    Zhang, Bei
    Wang, Zhi-Qiang
    Su, Yin-Xia
    Du, Guo-Li
    Wang, Shu-Xia
    Zhang, Zhao-Xia
    Hou, Qin-Qin
    Cai, Ren
    He, Fang-Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (09): : 4684 - 4694
  • [34] Prevalence and Determinants of Hyperuricemia in Type 2 Diabetes Mellitus Patients Attending Jimma Medical Center, Southwestern Ethiopia, 2019
    Arersa, Kumsa Kene
    Wondimnew, Tesaka
    Welde, Mengistu
    Husen, Tigist Mateos
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 2059 - 2067
  • [35] Efficacy of metformin on different adipocytokines in type 2 diabetes mellitus patients
    Hamdy, Naglaa
    Abdel-Gabbar, Mohamed
    Sakr, Hader I.
    Abdelaziz, Mohamed A.
    Kandeil, Mohamed
    Aziz, Ayman M. Abdel
    Ahmed, Osama M.
    EGYPTIAN PHARMACEUTICAL JOURNAL, 2024, 23 (02) : 207 - 215
  • [36] PATHOGENIC GLUT9 MUTATIONS CAUSING RENAL HYPOURICEMIA TYPE 2 (RHUC2)
    Kawamura, Y.
    Matsuo, H.
    Chiba, T.
    Nagamori, S.
    Nakayama, A.
    Inoue, H.
    Utsumi, Y.
    Oda, T.
    Nishiyama, J.
    Kanai, Y.
    Shinomiya, N.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2011, 30 (12) : 1105 - 1111
  • [37] Polysomnographic Phenotypes of Obstructive Sleep Apnea and Incident Type 2 Diabetes Results from the DREAM Study
    Ding, Qinglan
    Qin, Li
    Wojeck, Brian
    Inzucchi, Silvio E.
    Ibrahim, Ahmad
    Bravata, Dawn M.
    Strohl, Kingman P.
    Yaggi, Henry K.
    Zinchuk, Andrey, V
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (12) : 2067 - 2078
  • [38] Polystyrene nanoplastics with different functional groups and charges have different impacts on type 2 diabetes
    Wang, Yunyi
    Xu, Ke
    Gao, Xiao
    Wei, Zhaolan
    Han, Qi
    Wang, Shuxin
    Du, Wanting
    Chen, Mingqing
    PARTICLE AND FIBRE TOXICOLOGY, 2024, 21 (01)
  • [39] Two cases of type 2 diabetes mellitus successfully treated with probiotics
    Cardinali, Nestor
    Bauman, Carlos
    Rodriguez Ayala, Facundo
    Grau, Roberto
    CLINICAL CASE REPORTS, 2020, 8 (12): : 3119 - 3124
  • [40] Prevalence of Hyperuricemia and Associated Factors Among Patients With Type 2 Diabetes Mellitus in Northwestern Tanzania: A Cross-Sectional Study
    Abdel, Kulthum A.
    Kalluvya, Samuel E.
    Sadiq, Abid M.
    Ashir, Abdel
    Masikini, Peter I.
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2024, 17